Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $836,429 - $1.25 Million
2,468 Added 17.64%
16,460 $6.26 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $1.09 Million - $1.61 Million
2,942 Added 26.62%
13,992 $6.88 Million
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $169,986 - $199,457
472 Added 4.46%
11,050 $4.31 Million
Q1 2023

May 15, 2023

SELL
$334.23 - $403.65 $1.55 Million - $1.87 Million
-4,640 Reduced 30.49%
10,578 $3.94 Million
Q4 2022

Feb 14, 2023

BUY
$342.17 - $402.31 $778,778 - $915,657
2,276 Added 17.59%
15,218 $5.77 Million
Q3 2022

Nov 14, 2022

SELL
$343.2 - $395.75 $736,507 - $849,279
-2,146 Reduced 14.22%
12,942 $4.57 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $1.42 Million - $2 Million
5,268 Added 53.65%
15,088 $5.72 Million
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $20,356 - $28,084
-80 Reduced 0.81%
9,820 $3.1 Million
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $681,385 - $884,340
-2,505 Reduced 20.19%
9,900 $3.47 Million
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $265,795 - $315,872
-901 Reduced 6.77%
12,405 $3.75 Million
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $122,384 - $152,281
476 Added 3.71%
13,306 $4.01 Million
Q1 2021

May 14, 2021

BUY
$268.3 - $380.31 $8,317 - $11,789
31 Added 0.24%
12,830 $3.53 Million
Q4 2020

Feb 16, 2021

SELL
$248.13 - $308.36 $597,000 - $741,914
-2,406 Reduced 15.82%
12,799 $3.76 Million
Q3 2020

Nov 16, 2020

BUY
$215.51 - $272.51 $36,421 - $46,054
169 Added 1.12%
15,205 $3.99 Million
Q2 2020

Aug 14, 2020

SELL
$127.44 - $232.72 $1.13 Million - $2.06 Million
-8,849 Reduced 37.05%
15,036 $3.39 Million
Q1 2020

May 15, 2020

SELL
$108.83 - $165.23 $1.21 Million - $1.84 Million
-11,115 Reduced 31.76%
23,885 $3.15 Million
Q3 2019

Nov 14, 2019

SELL
$113.31 - $150.51 $339,930 - $451,530
-3,000 Reduced 7.89%
35,000 $3.99 Million
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $460,000 - $566,320
-4,000 Reduced 9.52%
38,000 $5.38 Million
Q1 2019

May 15, 2019

BUY
$98.85 - $134.59 $197,700 - $269,180
2,000 Added 5.0%
42,000 $5.24 Million
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $1.29 Million - $2.22 Million
-20,188 Reduced 33.54%
40,000 $3.84 Million
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $1.52 Million - $1.95 Million
20,188 Added 50.47%
60,188 $4.57 Million
Q2 2018

Aug 14, 2018

BUY
$74.84 - $100.16 $374,200 - $500,800
5,000 Added 14.29%
40,000 $3.31 Million
Q1 2018

May 15, 2018

SELL
$56.95 - $85.19 $170,850 - $255,570
-3,000 Reduced 7.89%
35,000 $2.82 Million
Q4 2017

Feb 14, 2018

BUY
$22.57 - $63.56 $383,690 - $1.08 Million
17,000 Added 80.95%
38,000 $2.4 Million
Q3 2017

Nov 14, 2017

BUY
$19.81 - $22.61 $416,010 - $474,810
21,000
21,000 $475,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.